Please login to the form below

Not currently logged in

WHO takes stock of global COVID-19 R&D progress


Researchers and developers meet virtually to discuss progress

Abivax doses first patient in phase 2b/3 COVID-19 clinical trial

AbivaxStudy will evaluate experimental anti-inflammatory drug

Pfizer jumps on early data from BioNTech-partnered COVID-19 vaccine study

Pfizer logoPreliminary data demonstrates promising immunogenicity

Inovio slips on “positive results” for COVID-19 vaccine

Coronavirus vaccineLack of clear information in first human data raises questions

Remdesivir closes in on receiving first EU approval for treatment for COVID-19

GileadFirst drug shown to have an effect on COVID-19 in controlled clinical trials

NICE knocks back Novartis’ oral MS drug Mayzent in draft guidance

Novartis buildingDrug has been found to reduce disability progression by 33%

Sanofi accelerates coronavirus vaccine plans

Sanofi receptionCompany will start clinical testing in September, several months earlier than planned

Gilead spends $275m on half-share in immuno-oncology firm Pionyr

Daniel O'DayWith an option to buy the entire company outright for another $315m

Gilead will test inhaled remdesivir in earlier-stage COVID-19

GileadPhase 1 trial due to start in August

clusterAdopting a creative IP approach towards biotech clusters

Why big pharma paradigm needs to change

COVID-19 Updates and Daily News

Featured jobs


Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

The search for treatments for Parkinson’s disease
The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...
Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
Ditch the Label – it’s just me....
The impact of COVID-19 on clinical trials
As all industry sectors work to assess both the impact and the optimal path forward, the effects are expected to be diverse and long-lasting...